These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7542099)

  • 1. Effect of fluticasone propionate on acute and chronic inflammation.
    Johnson M
    Int Arch Allergy Immunol; 1995; 107(1-3):441-2. PubMed ID: 7542099
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-inflammatory properties of fluticasone propionate.
    Johnson M
    Int Arch Allergy Immunol; 1995; 107(1-3):439-40. PubMed ID: 7613206
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of salmeterol xinafoate and fluticasone propionate on immunological activation of human cultured mast cells.
    Akabane H; Murata M; Kubota M; Takashima E; Tanaka H; Inagaki N; Horiba M; Nagai H
    Allergol Int; 2006 Dec; 55(4):387-93. PubMed ID: 17130681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of wortmannin on human eosinophil responses in vitro and on bronchial inflammation and airway hyperresponsiveness in Guinea pigs in vivo.
    Ezeamuzie CI; Sukumaran J; Philips E
    Am J Respir Crit Care Med; 2001 Nov; 164(9):1633-9. PubMed ID: 11719302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fluticasone propionate--a new name common in asthma and rhinitis].
    Ulmeanu R; Mihălţan F
    Pneumoftiziologia; 1997; 46(1):63-4. PubMed ID: 9289240
    [No Abstract]   [Full Text] [Related]  

  • 6. [Topical corticosteroids, a timely class of drugs. A new class II topical corticosteroid: fluticasone propionate].
    Presse Med; 2001 Apr; 30(13):659-63. PubMed ID: 11346910
    [No Abstract]   [Full Text] [Related]  

  • 7. Intranasal fluticasone propionate inhibits allergen induced bone marrow eosinophilia in mice.
    Sergejeva S; Tomaki M; Pullerits T; Zhao LL; Johnson M; Lötvall J
    Pulm Pharmacol Ther; 2002; 15(2):129-34. PubMed ID: 12090786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-response relationships for chemical sensitization from TDI and DNCB.
    Huang J; Wang XP; Chen BM; Zhou XJ; Matsushita T
    Bull Environ Contam Toxicol; 1993 Nov; 51(5):732-9. PubMed ID: 7694697
    [No Abstract]   [Full Text] [Related]  

  • 9. Once daily intranasal fluticasone propionate is effective for perennial allergic rhinitis.
    Banov CH; Woehler TR; LaForce CF; Pearlman DS; Blumenthal MN; Morgan WF; Frazer H; Southern DL; Gold B; Field E
    Ann Allergy; 1994 Sep; 73(3):240-6. PubMed ID: 8092559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophil markers in seasonal allergic rhinitis. Intranasal fluticasone propionate inhibits local and systemic increases during the pollen season.
    Nielsen LP; Bjerke T; Christensen MB; Skamling M; Peterson CG; Mygind N; Dahl R
    Allergy; 1998 Aug; 53(8):778-85. PubMed ID: 9722227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic and pharmacodynamic evaluation of the suitability of using fluticasone and an acute rat lung inflammation model to differentiate lung versus systemic efficacy.
    Chiang PC; Hu Y; Thurston A; Sommers CD; Guzova JA; Kahn LE; Lai Y; Blom JD
    J Pharm Sci; 2009 Nov; 98(11):4354-64. PubMed ID: 19230021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study.
    Hattotuwa KL; Gizycki MJ; Ansari TW; Jeffery PK; Barnes NC
    Am J Respir Crit Care Med; 2002 Jun; 165(12):1592-6. PubMed ID: 12070058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of intranasal cortocosteroidson on the expression of Aquaporin-5 in human nasal polyps].
    Li Z; Gao Q; Zhen H; Cui Y
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Nov; 18(11):647-9. PubMed ID: 15715403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluticasone propionate downregulates nasal fibroblast functions involved in airway inflammation and remodeling.
    Silvestri M; Sabatini F; Scarso L; Cordone A; Dasic G; Rossi GA
    Int Arch Allergy Immunol; 2002 May; 128(1):51-8. PubMed ID: 12037401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter trial of fluticasone propionate aqueous nasal spray in ragweed allergic rhinitis.
    Dolovich J; Wong AG; Chodirker WB; Drouin MA; Hargreave FE; Hebert J; Knight A; Small P; Yang WH
    Ann Allergy; 1994 Aug; 73(2):147-53. PubMed ID: 8067598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluticasone propionate nasal spray for allergic rhinitis.
    Med Lett Drugs Ther; 1995 Jan; 37(940):5-6. PubMed ID: 7815981
    [No Abstract]   [Full Text] [Related]  

  • 17. Preclinical profile of ciclesonide, a novel corticosteroid for the treatment of asthma.
    Belvisi MG; Bundschuh DS; Stoeck M; Wicks S; Underwood S; Battram CH; Haddad el-B; Webber SE; Foster ML
    J Pharmacol Exp Ther; 2005 Aug; 314(2):568-74. PubMed ID: 15878996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in nasal reactivity in patients with rhinitis medicamentosa after treatment with fluticasone propionate and placebo nasal spray.
    Graf PM; Hallén H
    ORL J Otorhinolaryngol Relat Spec; 1998; 60(6):334-8. PubMed ID: 9742282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of salmeterol and fluticasone propionate combination versus fluticasone propionate on airway function and eosinophilic inflammation in mild asthma.
    Hoshino M; Handa H; Miyazawa T
    Allergol Int; 2009 Sep; 58(3):357-63. PubMed ID: 19454840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bronchodilator reversibility, airway eosinophilia and anti-inflammatory effects of inhaled fluticasone in COPD are not related.
    Reid DW; Wen Y; Johns DP; Williams TJ; Ward C; Walters EH
    Respirology; 2008 Nov; 13(6):799-809. PubMed ID: 18811878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.